Burden of HIV among young transgender women: factors associated with HIV infection and HIV treatment engagement.
Adolescent
Adult
Anti-HIV Agents
/ therapeutic use
Boston
/ epidemiology
Chicago
/ epidemiology
Continuity of Patient Care
Delivery of Health Care
Female
HIV Infections
/ drug therapy
Health Knowledge, Attitudes, Practice
Health Services Accessibility
Humans
Prevalence
Transgender Persons
/ psychology
Young Adult
HIV
HIV treatment cascade
access to care
young transgender women
Journal
AIDS care
ISSN: 1360-0451
Titre abrégé: AIDS Care
Pays: England
ID NLM: 8915313
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
pubmed:
2
11
2018
medline:
20
11
2019
entrez:
2
11
2018
Statut:
ppublish
Résumé
Young transgender women (YTW) are disproportionately affected by HIV, however, little is known about the factors associated with HIV infection and treatment engagement. We examined correlates of HIV infection and the steps of the HIV treatment cascade, specifically, being aware of their HIV infection, linked to care, on ART, and adherent to ART. We analyzed the baseline data of Project LifeSkills, a randomized control trial of sexually active YTW recruited from Chicago, Illinois and Boston, Massachusetts. We conducted multivariable Poisson regressions to evaluate correlates of HIV infection and the steps of the HIV treatment cascade. Nearly a quarter (24.7%) of YTW were HIV-infected. Among HIV-infected YTW, 86.2% were aware of their HIV status, 72.3% were linked to care, 56.9% were on ART, and 46.2% were adherent to ART. Having avoided healthcare due to cost in the past 12 months and not having a primary care provider were associated with suboptimal engagement in HIV care. Our results suggest that improving linkage and retention in care by addressing financial barriers and improving access to primary care providers could significantly improve health outcomes of YTW as well as reduce forward transmission of HIV.
Identifiants
pubmed: 30380926
doi: 10.1080/09540121.2018.1539213
pmc: PMC6250572
mid: NIHMS1511065
doi:
Substances chimiques
Anti-HIV Agents
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
125-130Subventions
Organisme : NIMH NIH HHS
ID : R01 MH094323
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001422
Pays : United States
Références
Am J Public Health. 2016 Mar;106(3):497-502
pubmed: 26691124
LGBT Health. 2017 Jun;4(3):181-187
pubmed: 28498011
J Acquir Immune Defic Syndr. 2008 May 1;48(1):97-103
pubmed: 18344875
AIDS Behav. 2017 Dec;21(12):3312-3327
pubmed: 29138982
BMC Public Health. 2017 Sep 16;17(1):713
pubmed: 28915919
Lancet Infect Dis. 2013 Mar;13(3):214-22
pubmed: 23260128
MMWR Morb Mortal Wkly Rep. 2017 Aug 25;66(33):883-887
pubmed: 28837547
Am J Public Health. 2009 Apr;99(4):713-9
pubmed: 19150911
Sex Transm Infect. 2014 Aug;90(5):430-3
pubmed: 24714446
Am J Public Health. 2015 Jun;105(6):1114-9
pubmed: 25880937
Soc Sci Med. 2015 Dec;147:222-31
pubmed: 26599625
J Urban Health. 2015 Jun;92(3):584-92
pubmed: 25779756
JAMA Pediatr. 2016 May 1;170(5):481-6
pubmed: 26999485
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3:S226-9
pubmed: 27429187